Trametinib as a promising therapy for Darier disease: case report
British Journal of Dermatology · 17.07.2025 · 193 (2) · 339-341
DOI: 10.1093/bjd/ljaf160 ↗Kurz gefasst
Fallbericht in der Zeitschrift British Journal of Dermatology, online erschienen am 25.04.2025. Verfasst von Diego Soto-García und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Complexo Hospitalario Universitario de Vigo, Vigo, Spain. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Darier disease (DD) is a rare autosomal-dominant genodermatosis caused by mutations in the ATP2A2 gene, which encodes sarco-endoplasmic reticulum calcium ATPase 2 (SERCA2). This leads to impaired intercellular adhesion and epidermal blistering. We report the case of a 25-year-old man with severe DD who demonstrated a positive response to trametinib after multiple unsuccessful therapies.
Autor:innen und Institutionen
- Dermatology Department, Complexo Hospitalario Universitario de Vigo, Vigo, Spain.
ORCID-Profile: Diego Soto-García, Ignacio García-Doval
Zitieren
APA
Soto-García, D., Dávila-Seijo, P., González-Moure, C., Pampín, A., Zulaica, A., Allegue, F., & García-Doval, I. (2025). Trametinib as a promising therapy for Darier disease: case report. British Journal of Dermatology, 193(2), 339-341. https://doi.org/10.1093/bjd/ljaf160
Vancouver
Soto-García D, Dávila-Seijo P, González-Moure C, Pampín A, Zulaica A, Allegue F, et al. Trametinib as a promising therapy for Darier disease: case report. British Journal of Dermatology. 2025;193(2):339-341. doi:10.1093/bjd/ljaf160
BibTeX
@article{SotoGarca2025,
author = {Soto-García, Diego and Dávila-Seijo, Paula and González-Moure, Carlota and Pampín, Ana and Zulaica, Ander and Allegue, Francisco and García-Doval, Ignacio},
title = {Trametinib as a promising therapy for Darier disease: case report},
journal = {British Journal of Dermatology},
year = {2025},
volume = {193},
number = {2},
pages = {339--341},
doi = {10.1093/bjd/ljaf160}
}
EUVIMED